BRAF and colorectal carcinoma: In our current study, univariable Kaplan-Meier curves showed that CRC-specific and overall survival differed significantly between patients with ﻿SARIFA-positive and SARIFA-negative CRCs across all molecular subgroups based on BRAF, RAS, and MMR status, except for the dMMR subgroup (Fig. 4 and Supplementary Figure S3, Supplemental Digital Content 1, http://links.lww.com/PAS/C100).